Guardian Pharmacy Services, Inc.
For the period ended Mar 31, 2025. Filed May 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 12, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
(Mark One)
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|
For the quarterly period ended March 31,2025
OR
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|
For the transition period from to
Commission File Number:
001-42284
Guardian Pharmacy Services, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 87-3627139 |
|---|---|
| (State or Other Jurisdiction ofIncorporation or Organization) | (I.R.S. EmployerIdentification No.) |
300 Galleria Parkway SE
Suite 800
Atlanta, Georgia 30339
(Address of Principal Executive Offices) (Zip Code)
(404)
810-0089
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | TradingSymbol(s) | Name of Each Exchangeon Which Registered |
|---|---|---|
| Class A Common Stock, par value $0.001 per share | GRDN | The New York Stock Exchange |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes: ☒
No
: ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes: ☒ No: ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in
Rule 12b-2
of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
|---|---|---|---|
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☒ | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2
of the Exchange Act). Yes: ☐ No:☒
As of May 1, 2025, there were issued and outstanding 22,719,946 shares of the registrant’s Class A common stock and 40,566,696 shares of the registrant’s Class B common stock.
GUARDIAN PHARMACY SERVICES, INC.
FORM 10-Q
TABLE OF CONTENTS
| SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS | 2 |
|---|---|
| PART I. FINANCIAL INFORMATION | |
| ITEM 1. Financial Statements (Unaudited) | 4 |
| Consolidated Balance Sheets | 4 |
| Consolidated Statements of Operations | 5 |
| Consolidated Statements of Changes in Members’ Equity and Stockholders’ Equity | 6 |
| Consolidated Statements of Cash Flows | 7 |
| Notes to the Unaudited Interim Consolidated Financial Statements | 8 |
| ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 18 |
| ITEM 3. Quantitative and Qualitative Disclosure about Market Risk | 26 |
| ITEM 4. Controls and Procedures | 27 |
| PART II. OTHER INFORMATION | |
| ITEM 1. Legal Proceedings | 27 |
| ITEM 1A. Risk Factors | 27 |
| ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds | 27 |
| ITEM 3. Defaults Upon Senior Securities | 28 |
| ITEM 4. Mine Safety Disclosures | 28 |
| ITEM 5. Other Information | 28 |
| ITEM 6. Exhibits | 29 |
| SIGNATURES | 30 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.